Xu, X., Yan, Y., Xun, Q., Shi, J., Kong, X., Wu, J., & Zhou, H. (2019). Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line. Onco Targets Ther.
Citação norma ChicagoXu, Xiaofeng, Yuhua Yan, Qingying Xun, Jiayu Shi, Xiangyi Kong, Jun Wu, and Huaijun Zhou. "Combined Silencing of VEGF-A and Angiopoietin-2, a More Effective Way to Inhibit the Ishikawa Endometrial Cancer Cell Line." Onco Targets Ther 2019.
Deismireacht MLAXu, Xiaofeng, et al. "Combined Silencing of VEGF-A and Angiopoietin-2, a More Effective Way to Inhibit the Ishikawa Endometrial Cancer Cell Line." Onco Targets Ther 2019.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.